Oramed Pharmaceuticals
(NASDAQ:ORMP)
$4.60
0.02[0.44%]
At close: Jul 1
$4.60
00
After Hours: 4:30PM EDT
Day High/Low4.46 - 4.76
52 Week High/Low3.59 - 31.54
Open / Close4.58 / 4.6
Float / Outstanding37.3M / 38.6M
Vol / Avg.469.3K / 815K
Mkt Cap177.4M
P/E-
50d Avg. Price4.72
Div / Yield-
Payout Ratio-
EPS-0.27
Total Float37.3M

Oramed Pharmaceuticals (NASDAQ:ORMP), Quotes and News Summary

Oramed Pharmaceuticals (NASDAQ: ORMP)

Day High/Low4.46 - 4.76
52 Week High/Low3.59 - 31.54
Open / Close4.58 / 4.6
Float / Outstanding37.3M / 38.6M
Vol / Avg.469.3K / 815K
Mkt Cap177.4M
P/E-
50d Avg. Price4.72
Div / Yield-
Payout Ratio-
EPS-0.27
Total Float37.3M
Benzinga - Apr 5, 2022, 8:25AM
Benzinga - Jan 12, 2022, 8:46AM
Benzinga - Nov 24, 2021, 8:40AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-07-18
REV
Q2 2022Est.ActualSurprise
EPS-0.230-0.270 -0.0400
REV666.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Oramed Pharmaceuticals Questions & Answers

Q
How do I buy Oramed Pharmaceuticals (ORMP) stock?
A

You can purchase shares of Oramed Pharmaceuticals (NASDAQ: ORMP) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Oramed Pharmaceuticals's (ORMP) competitors?
Q
What is the target price for Oramed Pharmaceuticals (ORMP) stock?
A

The latest price target for Oramed Pharmaceuticals (NASDAQ: ORMP) was reported by Aegis Capital on Monday, May 16, 2022. The analyst firm set a price target for 30.00 expecting ORMP to rise to within 12 months (a possible 552.17% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Oramed Pharmaceuticals (ORMP)?
A

The stock price for Oramed Pharmaceuticals (NASDAQ: ORMP) is $4.6 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Oramed Pharmaceuticals (ORMP) pay a dividend?
A

There are no upcoming dividends for Oramed Pharmaceuticals.

Q
When is Oramed Pharmaceuticals (NASDAQ:ORMP) reporting earnings?
A

Oramed Pharmaceuticals’s Q3 earnings are confirmed for Monday, July 18, 2022.

Q
Is Oramed Pharmaceuticals (ORMP) going to split?
A

There is no upcoming split for Oramed Pharmaceuticals.

Q
What sector and industry does Oramed Pharmaceuticals (ORMP) operate in?
A

Oramed Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.